D.A. Davidson & Co’s NeoGenomics NEO Stock Holding History

D.A. Davidson & Co’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,419	Closed	-$315K	–	1101
2019 Q1	$315K	Buy	+15,419	New	+$268K	0.01%	859

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

D.A. Davidson & Co's NEO Position: Q2 2019 in Review

D.A. Davidson & Co sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 15,419 shares — an estimated $315K sold.

D.A. Davidson & Co first reported a position in NEO in Q1 2019 and held it in 1 quarter. The position peaked at $315K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

D.A. Davidson & Co reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
D.A. Davidson & Co sold 15,419 NeoGenomics shares in Q2 2019, an estimated $315K.
D.A. Davidson & Co first reported a position in NeoGenomics in Q1 2019 and held it in 1 quarter.
D.A. Davidson & Co's NeoGenomics position peaked at $315K in Q1 2019.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.